Clovis Oncology, Inc. (NASDAQ:CLVS) last session’s volume of 1.37 million shares was lower than its average volume of 1.59 million shares. The stock, after opening at $81.5, hit $78.72 through the close by scoring -3.2%.Clovis Oncology, Inc. (CLVS) Analyst Opinion
Clovis Oncology, Inc. has a consensus outperform rating from 13 Wall Street analysts, and the number of shares currently sold short amount to at least 16.99% of shares outstanding. The stock spiked 3.57% last month and is up 77.22 this year. Wall Street is only getting more bullish on the stock, with 9 of analysts who cover CLVS having a buy-equivalent rating. Analysts have placed a $93.73 price target on Clovis Oncology, Inc., suggesting a 19.07% gain from recent close. It’s currently trading about -20.84% below its 52-week high.
Clovis Oncology, Inc. (CLVS) surprised the stock market in its last reported earnings when it earned -$1.29 a piece versus the consensus-estimated -$2.13. Its revenue totaled $13.31 million up 88.79% from the previous quarter.Clovis Oncology, Inc. (NASDAQ:CLVS) Intraday View
This stock (CLVS) is ahead of its 52-week low with 205%. Its last month’s stock price volatility remained 4.15% which for the week stands at 4.57%. The share price has moved backward from its 20 days moving average, trading at a distance of -2.47% and stays 3.99% away from its 50 days moving average. Over the last five days, shares have faced -4.9% losses and now is up 15.64% since hitting its 200-day moving average of $71.4. Clovis Oncology, Inc. (CLVS) has made its way to a 12-month gain of 139.05%.
Turning to Cogint, Inc. (NASDAQ:COGT), its shares were trading at $4.75 a gain of $0.15, on the trading floor. The stock touched a high of $10.5 before paring much of its gains. So far, analysts are sticking with their bullish recommendations with the consensus call at 1.7. Cogint, Inc. has 0 buy ratings, 0 holds and 0 sells even after the stock tumbled -24.6% from its high of $11.33 to a $272.98 million market value through last close.
The company’s consensus rating on Reuter’s scale remained unchanged from 2 to 2 during a month. Analysts set a 12-month price target of $9.38 a share. The target implies a 97.47% spike from where the shares are currently trading. Also, the current price highlights a discount of 163.16% to analysts’ high consensus price target.Cogint, Inc. (NASDAQ:COGT) Intraday Trading
The counter witnessed a trading volume of 0.25 million shares versus an average volume of 0.17 million shares during last trading session. Its last month’s stock price volatility remained 5.96% which for the week approaches 4.45%. The lowest price the stock reached in the last trading day was $10.5 and compares with the $8.37 52-week low. The stock recovered 63.79% since its low point and has performed 37.68% year-to-date.